Ravindra Nayakwadi
About Ravindra Nayakwadi
Ravindra Nayakwadi is the Director of Analytical Research and Development at Omniactive Health Technologies, where he has worked since 2017. He has extensive experience in the pharmaceutical industry, having held various analytical and research positions at companies such as Cipla, Glenmark Pharmaceuticals, USV Limited, and Novartis.
Work at OmniActive Health Technologies
Ravindra Nayakwadi has been serving as the Director of Analytical Research and Development at OmniActive Health Technologies since 2017. In this role, he oversees various analytical projects and initiatives, contributing to the company's research and development efforts. His position is based in Thane, Maharashtra, India, where he has been instrumental in advancing the analytical capabilities of the organization.
Previous Experience in Pharmaceutical Industry
Prior to his current role, Nayakwadi accumulated extensive experience in the pharmaceutical sector. He worked at Cipla as an analyst from 2000 to 2002 in Bombay, Maharashtra. Following this, he served as a research officer at Glenmark Pharmaceuticals from 2002 to 2004. His career continued at Novartis, where he held the position of group expert in quality compliance from 2004 to 2012. He later joined USV Limited as a senior manager in the analytical research lab, working there from 2014 to 2017.
Education and Expertise
Ravindra Nayakwadi possesses a strong educational background that supports his expertise in analytical research and development. His professional journey in the pharmaceutical industry has equipped him with a deep understanding of quality compliance and analytical processes, which he applies in his current role at OmniActive Health Technologies.
Career Progression in Analytical Research
Nayakwadi's career in analytical research has shown a clear progression through various roles in reputable pharmaceutical companies. His initial position as an analyst at Cipla laid the foundation for his subsequent roles, including his tenure at Glenmark Pharmaceuticals and Novartis. His experience culminated in a senior management position at USV Limited before taking on his current directorial role at OmniActive Health Technologies.